How Health Plans Can Harness Data and Thrive in Medicare Advantage Markets

Published on February 26, 2019

Health plans competing in the Medicare Advantage market have common goals: acquire, retain, and engage members, preferably at higher rates than other plans in the same market. Unfortunately, many plans pursue these goals without the benefit of deep and timely market intelligence. Lacking the infrastructure to access, manage, and leverage timely and accurate data easily and cost-effectively, they are impeded by limited understanding of their customers, their competitors, and their own market position.

Medicare Advantage plans – especially mid-sized regional plans – must work smarter to compete against the national players. The future belongs to organizations that power their strategic and operational decisions with data-driven insights.

Our latest white paper, “The Insight-Driven Health Plan,” details the value of leveraging the right data and doing so with purpose. Strategic benefits include

  • informed decisions that support organizational goals;
  • plan designs that reflect consumer-friendly options around price, benefits and services;
  • better and more timely responses to competition and changing market dynamics;
  • identification of meaningful opportunities for growth and member capture; and
  • insights that are predictive of future trends.

Download the white paper now to learn how you can use market intelligence to answer fundamental questions about your plan’s strategic position, what new product offerings make sense and which markets to target for entry or expansion. It’s time to take the guesswork and randomness out of these decisions. With Carrot MarketView Essentials, you gain an advantage over your competition with access to timely, accurate insights helping all departments align with overall strategic goals, drive growth, reduce costs, and improve patient outcomes.

Related Posts


Local and Individualized SDoH Data Is Critical to Advancing Health Equity


How Health Plans Can Improve the ROI of In-Home Test Kits


Q&A on the Carrot Community Committee (C3)